AP reported that "concerning vitals" quote is from COS Meadows, too, which just makes it yet more insane. is Meadows at odds with Trump?? not to mention the most recent statement from Dr. Conley incorrectly spells Regeneron, misattributes a statement to himself, and isn't signed by anyone?? hard to imagine they could handle this any worse than they are.
AP reported that "concerning vitals" quote is from COS Meadows, too, which just makes it yet more insane. is Meadows at odds with Trump?? not to mention the most recent statement from Dr. Conley incorrectly spells Regeneron, misattributes a statement to himself, and isn't signed by anyone?? hard to imagine they could handle this any worse than they are.
oh, and Regeneron had to cleanup the statement further to say that it's actually two monoclonal antibodies and not a polyclonal antibody therapy as that masterclass statement reads.
See, and all this would be grossly incompetent if your company was rolling out, say, a new product...but this is the WHITE HOUSE and the PRESIDENT OF THE UNITED STATES, not version 3.0 of the new colored Post-It note. I mean, we could get 4 of us together right now and handle this better than they are currently.
AP reported that "concerning vitals" quote is from COS Meadows, too, which just makes it yet more insane. is Meadows at odds with Trump?? not to mention the most recent statement from Dr. Conley incorrectly spells Regeneron, misattributes a statement to himself, and isn't signed by anyone?? hard to imagine they could handle this any worse than they are.
oh, and Regeneron had to cleanup the statement further to say that it's actually two monoclonal antibodies and not a polyclonal antibody therapy as that masterclass statement reads.
See, and all this would be grossly incompetent if your company was rolling out, say, a new product...but this is the WHITE HOUSE and the PRESIDENT OF THE UNITED STATES, not version 3.0 of the new colored Post-It note. I mean, we could get 4 of us together right now and handle this better than they are currently.